Navigation Links
Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
Date:11/25/2008

ll assume Ms. Loewy's responsibilities while the company conducts a search to fill the chief financial officer position.

"I would like to thank David and Caroline for their past contributions to the company and wish them well in their future endeavors," added Dr. McMahon. "Our business fundamentals remain strong and we are focused on execution and completion of our ongoing clinical trials to generate data next year to support product commercialization and to continued development of picoplatin in the treatment of lung, colorectal and prostate cancers."

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Clinical trials of intravenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and hormone-refractory prostate cancers, as well as a clinical trial of oral picoplatin in solid tumors. Picoplatin has not been approved by any regulatory authority for use in humans. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's business objectives and strategic goals, drug development plans, timing and results of clinical trials and the potential safety and efficacy of its products in development. The Company's actual results may differ materially from those indicated
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 /PRNewswire-iReach/ -- This is a ... Chinese Heparin sodium (CAS 9041-08-1) & calcium (CAS ... information of Heparin sodium (CAS 9041-08-1) & calcium ... technology. The report then explores global and China,s ... calcium (CAS 37270-89-6) listing their product specification, capacity, ...
(Date:7/30/2014)... -- Hospira, Inc. (NYSE: HSP ), the ... technologies, today reported results for the second quarter ... quarter were $1.1 billion and adjusted* diluted earnings ... items as described later in this press release ... Accepted Accounting Principles (GAAP) basis, second-quarter 2014 diluted ...
(Date:7/30/2014)... , July 30, 2014   Medical Equipment Solutions, ... been awarded a Department of Defense (US Army) contract ... supply a mobile MRI diagnostic machine and technical support ... (WOSB) through the Small Business Administration (SBA), Medical Equipment ... field with the latest medical diagnostic equipment. The SBA ...
Breaking Medicine Technology:Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... 24, 2012 Marking a major milestone for ... a developer of oral drug delivery systems, announced today that ... Australian Patent Office. The patent covers an important part of ... of peptides. Oramed,s portfolio now consists of one issued patent ...
... Jan. 24, 2012  LoneStar Heart Inc., based here, today ... and Mark Maciejewski to the company,s board of directors. ... the board for LoneStar Heart; Frank Ahmann, the company,s ... executive officer of Vessix Vascular, Inc.; and Eric N. ...
Cached Medicine Technology:Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins 2LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors 2LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors 3
(Date:7/30/2014)... 30, 2014 Computer Resources of America, ... in New York City, has been awarded the contract ... headquarters of a large global bank. The bank is ... Chico Ramnarayan, CEO of CRA said, “Being awarded this ... to further develop what has already been a successful ...
(Date:7/30/2014)... According to the Yeast Infection No More book review ... will help candida sufferers get rid of their yeast ... to readers the truth about yeast infection and the real ... will discover natural and safe remedies to relieve symptoms of ... irritation of the vagina or vulva. , Vkool reveals ...
(Date:7/30/2014)... Seattle, WA (PRWEB) July 30, 2014 According ... by Vkool.com, this is a comprehensive bodybuilding guide for men ... press by up to 50 pounds in within a ... routine that will help keep their shoulders healthy and avoid ... that the Critical Bench Program 2.0 uncovers to learners the ...
(Date:7/30/2014)... My Clients Plus ( http://www.MyClientsPlus.com ) ... therapy note templates. Healthcare providers can now create ... all while meeting the HIPPA security requirements.     , ... (EMR) consist of psychological intake forms, treatment plan ... SOAP and DAP note formats are also available. ...
(Date:7/30/2014)... 2014 pMD, the leading innovator ... an Observation Result (ORU) interface to streamline cardiology ... customers are using the ORU interface to automate ... interpretations for electrocardiograms, echocardiograms, and stress tests. , ... the cardiology system produces electronic data for each ...
Breaking Medicine News(10 mins):Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 2Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 3Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 2Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 3Health News:My Clients Plus Announces Over 80 Online Therapy Notes to Help Healthcare Providers Go Paperless 2Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 2Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 3
... Phase I clinical trial of SNS-032, one of the ... cyclin-dependent kinases, demonstrated the drug,s safety and potential clinical ... are enzymatic proteins that are integrally involved in cellular ... key roles in the growth of cancers. The ...
... , ... Showcase How Harmony’s Human Services Solutions Are On the Front Lines of Health Care Reform ... Reston, VA (PRWEB) May ... health and human services management, announced today that it was one of 40 Expansion Stage ...
... overall health could explain the link, researchers say , ... study links moderate drinking to a lower risk for ... gets the credit. , Instead, the researchers say, people ... status, exercise more, suffer less depression and enjoy superior ...
... , ... Out About the Molly and Jason Honeymoon Experience, View Their Photos, and Learn What Footwear To ... Seattle, ... takes a job with the nation,s first online shoe retailer before embarking on her honeymoon, vowing ...
... ... Servers , ... NC (PRWEB) May 19, 2010 -- ORCS Web Inc., a specialist in Microsoft Windows-based ... announced that Microsoft’s newly released WCF RIA Services for Silverlight 4 has been made ...
... ... TakeThemAMeal.com, a Free Online Tool Designed to Coordinate the Delivery of Meals to Someone Who ... Harrisonburg, ... used to coordinate over 100,000 meal deliveries to people in need around the world. ...
Cached Medicine News:Health News:Drug in new class of targeted therapies shows early promise against blood-related cancers 2Health News:Drug in new class of targeted therapies shows early promise against blood-related cancers 3Health News:Harmony Information Systems Selected to Present at Exclusive MAVA Capital Connection 2010 Event 2Health News:Harmony Information Systems Selected to Present at Exclusive MAVA Capital Connection 2010 Event 3Health News:Study Challenges Notion That Moderate Drinking Protects the Heart 2Health News:Study Challenges Notion That Moderate Drinking Protects the Heart 3Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 2Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 3Health News:ORCS Web, Inc Makes Available WCF RIA Services 2
Shafts angled 45 degrees, 10 mm from tip to bend. 1 x 2 teeth. Serrated handle with polished finish. Most popular size or model....
Smooth pointed tips open to 3.0 mm. Straight shafts. Cross action. Round handle....
Flat handle 9 mm wide, angulated 45....
Straight tips with delicate serrations. Serrated handle with polished finish....
Medicine Products: